Caisse DE Depot ET Placement DU Quebec Purchases 30,724 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Caisse DE Depot ET Placement DU Quebec boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.5% in the third quarter, Holdings Channel.com reports. The firm owned 229,306 shares of the medical equipment provider’s stock after buying an additional 30,724 shares during the quarter. Caisse DE Depot ET Placement DU Quebec’s holdings in Intuitive Surgical were worth $112,651,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical in the 2nd quarter worth about $26,000. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. LRI Investments LLC purchased a new stake in Intuitive Surgical in the first quarter worth about $30,000. LGT Financial Advisors LLC lifted its holdings in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the company. Mizuho increased their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. BTIG Research increased their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday. Piper Sandler restated an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $526.06.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,459 shares of company stock valued at $26,080,251 in the last three months. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $542.00 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $552.00. The company has a market capitalization of $193.05 billion, a PE ratio of 87.14, a price-to-earnings-growth ratio of 5.30 and a beta of 1.39. The business’s fifty day moving average is $510.03 and its 200 day moving average is $468.41.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.